EFFECTS OF FLAVONOIDS ON THE RELEASE OF REACTIVE OXYGEN SPECIES BY STIMULATED HUMAN NEUTROPHILS. MULTIVARIATE ANALYSIS OF STRUCTURE-ACTIVITY RELATIONSHIPS(SAR).

Title	EFFECTS OF FLAVONOIDS ON THE RELEASE OF REACTIVE OXYGEN SPECIES BY STIMULATED HUMAN NEUTROPHILS. MULTIVARIATE ANALYSIS OF STRUCTURE-ACTIVITY RELATIONSHIPS(SAR).
Authors	LIMASSET,B: LE DOUCEN,C: DORE,JC: OJASO,T: DAMON,M: CRASTES DE PAULET,A:
Year	1993
Volume	46
Issue	7

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVAN	INACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVAN	INACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVAN	INACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVAN	INACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVAN	INACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVAN	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	WEAK ACTIVITY
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	WEAK ACTIVITY
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	ACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	WEAK ACTIVITY
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	ACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE	INACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE	INACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE	INACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE	INACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE	INACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	WEAK ACTIVITY
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	WEAK ACTIVITY
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	WEAK ACTIVITY
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGIN	INACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGIN	WEAK ACTIVITY
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGIN	INACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGIN	INACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGIN	INACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGIN	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	ACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	ACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	ACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN	INACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN	WEAK ACTIVITY
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN	INACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN	INACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN	INACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FUSTIN	ACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FUSTIN	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FUSTIN	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FUSTIN	WEAK ACTIVITY
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FUSTIN	WEAK ACTIVITY
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FUSTIN	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN	ACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN	ACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN	ACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	INACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	WEAK ACTIVITY
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	INACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	WEAK ACTIVITY
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	INACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	WEAK ACTIVITY
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	WEAK ACTIVITY
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	INACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	WEAK ACTIVITY
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	INACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	WEAK ACTIVITY
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	WEAK ACTIVITY
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
6	PHEROMONE(ANIMAL ESTRUS INHIBITOR)	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN	INACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN	INACTIVE
3	PHEROMONE(ANIMAL ESTRUS INHIBITOR)	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN	INACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN	INACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN	INACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	ACACETIN	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSMETIN	ACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSMETIN	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSMETIN	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSMETIN	ACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSMETIN	ACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSMETIN	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	GALANGIN	INACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	GALANGIN	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	GALANGIN	INACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	GALANGIN	ACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	GALANGIN	INACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	GALANGIN	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	INACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	ACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	ACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	ACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN	ACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN	ACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN	ACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	ACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	ACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	ACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN	ACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN	ACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN	ACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN,ISO:	ACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN,ISO:	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN,ISO:	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN,ISO:	ACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN,ISO:	ACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN,ISO:	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	INACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	INACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	WEAK ACTIVITY
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	ACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	ACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	WEAK ACTIVITY
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	WEAK ACTIVITY
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	ACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE	INACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE	INACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE	ACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE	WEAK ACTIVITY
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN METHYL CHALCONE	INACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN METHYL CHALCONE	WEAK ACTIVITY
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN METHYL CHALCONE	INACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN METHYL CHALCONE	WEAK ACTIVITY
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN METHYL CHALCONE	WEAK ACTIVITY
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERIDIN METHYL CHALCONE	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN	INACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN	INACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN	INACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN	WEAK ACTIVITY
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN	WEAK ACTIVITY
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULETIN	ACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULETIN	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULETIN	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULETIN	ACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULETIN	ACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULETIN	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	ACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	ACTIVE
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	ACTIVE
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETINIDIN	ACTIVE
2	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETINIDIN	ACTIVE
3	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETINIDIN	ACTIVE
4	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETINIDIN	WEAK ACTIVITY
5	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETINIDIN	WEAK ACTIVITY
6	POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INHIBITOR	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETINIDIN	INACTIVE

Citation 119930

Citation Details

Summary

Organisms and Their Experiments (32)

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Show SPARQL Queries (1)

Query 1